Agents for the treatment, prevention and diagnosis of bone disease available for licensing from Salk March 1, 2000
Joint effort by OSI, Wyeth-Ayerst results in identification of novel calcitonin-inducing agents Feb. 29, 2000
Potent human Y5 receptor antagonists bearing a novel heterocyclic core prepared at RWJPRI Feb. 28, 2000
RSS